Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Raghunand

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
British Journal of Cancer|June 11, 1999
Enhancement of chemotherapy by manipulation of tumour pHN Raghunand, X He, R van Sluis, et al.
Investigational New Drugs|June 20, 2012
A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancersA F Baker, K N Adab, N Raghunand, et al.
Neoplasia (New York, N.Y.)|August 10, 2000
Applications of magnetic resonance in model systems: cancer therapeuticsJ L Evelhoch, R J Gillies, G S Karczmar, et al.
Cancer Chemotherapy and Pharmacology|June 19, 2014
Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001)T Dragovich, D Laheru, F Dayyani, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
British Journal of Cancer|June 11, 1999
Enhancement of chemotherapy by manipulation of tumour pHN Raghunand, X He, R van Sluis, et al.
Investigational New Drugs|June 20, 2012
A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancersA F Baker, K N Adab, N Raghunand, et al.
Neoplasia (New York, N.Y.)|August 10, 2000
Applications of magnetic resonance in model systems: cancer therapeuticsJ L Evelhoch, R J Gillies, G S Karczmar, et al.
Cancer Chemotherapy and Pharmacology|June 19, 2014
Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001)T Dragovich, D Laheru, F Dayyani, et al.
Pageof 2